SEC 13F Intelligence

Birchview Capital, LP / CELG

Birchview Capital, LP’s Celgene Corp Position

Does Birchview Capital, LP own Celgene Corp (CELG)? Not currently — the last reported position was 699.6K shares worth $69M in Q3 2019; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$69M
Q3 2019
Shares
699.6K
% of Portfolio
+46.29%
Quarters Held
4
position exited

Position History CELG

Reported value by quarter
Q4 ’18: $45MQ4 ’18Q1 ’19: $66MQ1 ’19Q2 ’19: $64MQ2 ’19Q3 ’19: $69MQ3 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2019699.6K$69M+46.29%
Q2 2019697.7K$64M+39.22%
Q1 2019699.0K$66M+41.32%
Q4 2018699.0K$45M+42.38%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Birchview Capital, LP’s full portfolio or all institutional holders of CELG.